32% revenue growth is big though. You also need to compare this to expectations.
It seems to be in line with or above prospectus. That is positive.
And guiding to overall being in line with prospectus forecasts for FY25 too.
Sounds positive from an earnings perspective
- Forums
- ASX - By Stock
- Ann: 2024 Annual Report (including Appendix 4E)
GYG
guzman y gomez limited
Add to My Watchlist
1.62%
!
$29.41

32% revenue growth is big though. You also need to compare this...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$29.41 |
Change
0.470(1.62%) |
Mkt cap ! $3.019B |
Open | High | Low | Value | Volume |
$29.34 | $29.96 | $28.85 | $9.628M | 325.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1496 | $29.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$29.60 | 1418 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1496 | 29.370 |
4 | 1417 | 29.360 |
2 | 1733 | 29.320 |
4 | 2237 | 29.290 |
1 | 842 | 29.280 |
Price($) | Vol. | No. |
---|---|---|
29.600 | 1418 | 1 |
29.630 | 862 | 2 |
29.650 | 798 | 1 |
29.670 | 2157 | 3 |
29.680 | 798 | 1 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
GYG (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online